FDA Voices



What We Mean When We Talk About EvGen Part II

By Rachel E. Sherman MD, MPH, & Robert M. Califf MD – Earlier, we discussed a pair of concepts – interoperability and connectivity – that are essential prerequisites for the creation of a successful national system for evidence generation. We take a look at how we would apply these constructs as we go about building such a system.


What We Mean When We Talk About EvGen Part I

By Rachel E. Sherman MD, MPH, & Robert M. Califf MD – Across the clinical research enterprise, there is a growing awareness of serious shortfalls in the current paradigm of generating the scientific evidence that supports medical product evaluation and clinical care decisions and the need to modernize methods and expectations surrounding this evidence base.



Building a Case for Medical Device Interoperability

By Bakul Patel – As Yoda might say: build a case for interoperability, we must. While we may not have yet realized the technological accomplishments of Yoda’s advanced world, today connectivity shows great promise for the future. From blood pressure to brain scans, today’s health care allows for the rapid transfer and use of information between and among different medical devices.



What We Mean When We Talk About Data

By Robert M. Califf MD & Rachel Sherman MD, MPH – Medical care and biomedical research are in the midst of a data revolution. Networked systems, electronic health records, electronic insurance claims databases, social media, patient registries, and smartphones and other personal devices together comprise an immense new set of sources for data about health and healthcare.